MedTrace Logo

Effect Of Different Lining Materials in Stepwise Excavation

NCT01730287 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-11-21

No results posted yet for this study

Summary

Deep carious lesions will encounter the dentist with the challenge of selecting a treatment method that could avoid the pulpal exposure and maintain the pulp vitality.Conventional restorative treatments suggest complete removal of the caries in one visit which could cause pulpal exposure in 53% of the cases which in next step needs pulpotomy, pulpectomy or Root Canal Therapy (RCT).

Stepwise Excavation(SE)is an old concept but has been researched recently to reduce the possibility pulpal exposure during the removal of the lesion. Contrary to Indirect Pulp Capping (IPC), in this technique only the central infected part of the caries is removed in first visit and the rest of the caries will be lined by a suitable material to suppress the remained cariogenic biomass and seal the cavity. This will help the pulp to defend and survive. After a period, the cavity is re-opened and the rest of the caries which is darker, harder and with less bacteria will be removed and the tooth is restored permanently.The aim of this study was to compare the effect of different lining materials in clinical and radiographical symptoms in stepwise excavation without re-enter after one year.

Conditions

  • Dental Pulp Necrosis

Interventions

DRUG

Control

The teeth in this group restored only by filling material,without liner application.

DRUG

Calcium Hydroxide

Calcium Hydroxide paste applied.

DRUG

Mineral Trioxide Aggregate(MTA)

MTA applied .

DRUG

CEM cement

CEM cement applied .

Sponsors & Collaborators

  • Azad University of Medical Sciences

    lead OTHER

Principal Investigators

  • Sepideh Banava, Assist-Prof · Azad University of Medical Sciences, Dental Branch - Endodontics research center , SBMU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-12-31
Completion
2013-05-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01730287 on ClinicalTrials.gov